In the present study, we therefore investigated the efficacy of the anti-epidermal EGFR mAb, Nimotuzumab, on ESCC cells radiotherapy and its potential underlying mechanisms in vitro and in vivo. Here, EGFR is linked to esophageal squamous cell carcinoma.